Alliance Pharma's total assets for Q2 2024 were £398.31M, a decrease of -4.00% from the previous quarter. GB:APH total liabilities were £175.41M for the fiscal quarter, a -10.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.